$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
10:15am, Thursday, 29'th Dec 2022
These two biotechs are flying high right now.
FDA Approval, Top Funds Lift Drugmaker In Ailing Market
08:05am, Thursday, 29'th Dec 2022
Boosted by demand among the best mutual funds and an FDA approval, AbbVie shows strength in ailing market. The post FDA Approval, Top Funds Lift Drugmaker In Ailing Market appeared first on Investor's
5 Unstoppable Trends to Invest $5,000 in for 2023
05:52am, Thursday, 29'th Dec 2022
These trends won't fade away, and some of the companies that are positioned to ride them should be big winners.
Vertex: Progress Towards Expanding Cystic Fibrosis Market Continues
07:55am, Wednesday, 28'th Dec 2022
CF product revenues grew by 18% in Q3 of 2022 to $2.33 billion. TRIKAFTA continues uptake in the U.S. but larger 49% sales growth was observed in territories outside of the U.S. VX-522 is being develo
Is Vertex Pharmaceuticals a Buy?
06:15am, Tuesday, 27'th Dec 2022
There's more growth ahead for this biotech giant.
Here Are the Best Stocks To Own as 2022 Draws to a Close
05:30am, Monday, 26'th Dec 2022
They have what it takes to deliver growth over time.
After Doubling in the Past 6 Months, Is This Stock a Buy?
08:07am, Saturday, 24'th Dec 2022
This company has had a solid year, but there is still plenty of work ahead.
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
10:15am, Wednesday, 21'st Dec 2022
For many investors, now would be an opportune time to take advantage of great stocks trading at a discount.
Vertex Pharmaceuticals: Expect Growth Beyond Trikafta
11:16pm, Tuesday, 20'th Dec 2022
Vertex revenue grew 18% y/y in Q3 2022. The robust pipeline propels Vertex beyond the cystic fibrosis market.
Where Will Vertex Pharmaceuticals Be in 10 Years?
09:30am, Sunday, 18'th Dec 2022
Expect a bigger, more diversified, and more entrenched entity to emerge over the coming years.
Buying These Unstoppable Stocks Before 2023 Could Be a Genius Move
06:45am, Sunday, 18'th Dec 2022
These stocks have climbed by double digits this year.
Better Bear Market Buy: Vertex Pharmaceuticals vs. Biogen Stock
06:00am, Sunday, 18'th Dec 2022
Both stocks are heading for double-digit gains this year.
My 3 Best Stocks of 2022 -- and Why I Think They'll Win Again in 2023
05:55am, Sunday, 18'th Dec 2022
The momentum for these high-flying stocks should continue in the new year.
Should You Buy Stocks If a Recession Is Coming in 2023? Here's What History Shows.
05:52am, Saturday, 17'th Dec 2022
Stocks usually go down during recessions, but long-term investors can still come out on top.
4 Drug Stocks Up More Than 40% YTD With Room to Grow in 2023
09:47am, Friday, 16'th Dec 2022
Here are four drug companies, MRK, VRTX, IMCR and IMVT, that are up 40% or more in 2022 so far and still have room for growth in 2023.
Sign In
Buy VRTX